DELUCIA DAVID (Chief Financial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2026ACC: 0002040705-26-000003
Officer· Chief Financial Officer
Since Mar 2026
-60.00
Net shares
Net seller
$410.40
Total sold
0
Open market trades
0B · 0S
1
Total transactions
60.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−60.00
Price / share
$6.84
Trade value
$410.40
% of position
1.3%
3/6/2026
4.49K→4.43K
Total
Net shares
−60.00
Net value
-$410.40
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −60.00 | $6.84 | $410.40 | 1.3% | 4.49K | 4.43K |
| Total | −60.00 | -$410.40 | ||||||
Derivative Transactions0
No derivative transactions reported